Cargando…
Natalizumab treatment leads to an increase in circulating CXCR3-expressing B cells
OBJECTIVE: To study the effects of natalizumab treatment on subgroups of circulating peripheral blood B cell populations. METHODS: We studied the proportions and absolute numbers of CD19(+)CD20(+), CD10(+), and CD5(+) B cell populations, and determined very late activation antigen-4 and chemokine re...
Autores principales: | Saraste, Maija, Penttilä, Tarja-Leena, Airas, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079379/ https://www.ncbi.nlm.nih.gov/pubmed/27800533 http://dx.doi.org/10.1212/NXI.0000000000000292 |
Ejemplares similares
-
Exposure to natalizumab during pregnancy and lactation is safe – No
por: Airas, Laura
Publicado: (2020) -
Natalizumab treatment reduces microglial activation in the white matter of the MS brain
por: Sucksdorff, Marcus, et al.
Publicado: (2019) -
Association of serum neurofilament light with microglial activation in multiple sclerosis
por: Saraste, Maija, et al.
Publicado: (2023) -
Effect of Natalizumab on Circulating CD4(+) T-Cells in Multiple Sclerosis
por: Börnsen, Lars, et al.
Publicado: (2012) -
Natalizumab in the treatment of multiple sclerosis
por: Brown, Brandon A
Publicado: (2009)